Kristin Abate

Kristin Abate

Comptroller/Controller/Auditor at KARYOPHARM THERAPEUTICS INC.

Net worth: 12 324 $ as of 2026-10-30

41 year
Consumer Services
Health Technology

Profile

Kristin Abate is currently Chief Accounting Officer & Executive VP at Karyopharm Therapeutics, Inc., a position held since 2025.
Education includes graduate studies at Boston College and undergraduate studies at Bryant University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-10-15 18,616 ( 0.08% ) 12 324 $ 2026-10-30

Kristin Abate active positions

CompaniesPositionStart
KARYOPHARM THERAPEUTICS INC. Comptroller/Controller/Auditor 2019-06-30

Education of Kristin Abate

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

45

1st degree connections

3

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies3

Consumer Services

Consumer Services

Health Technology